Achieve Life Sciences (ACHV) Is Spiking Higher After Partnership Expands
Achieve Life Sciences (ACHV) announced Wednesday morning that it has agreed to amend its Technology Licence Agreement with the University of Bristol. The company has been granted exclusive rights for all human medicinal uses of cytisine derivatives created under the agreement.
Source: RTTNews